Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

Nasotracheal suctioning — 2004 revision & update.

BIBLIOGRAPHIC SOURCE(S)

  • American Association for Respiratory Care. Nasotracheal suctioning--2004 revision & update. Respir Care 2004 Sep;49(9):1080-4. [62 references]

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: American Association for Respiratory Care (AARC). AARC clinical practice guideline. Nasotracheal suctioning. Respir Care 1992 Aug;37(8):898-901.

BRIEF SUMMARY CONTENT

 
RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

Procedure

Nasotracheal suctioning (NTS) for tracheal aspiration is a component of bronchial hygiene therapy.

Description/Definition

NTS is intended to remove accumulated saliva, pulmonary secretions, blood, vomitus, and other foreign material from the trachea and nasopharyngeal area that cannot be removed by the patient's spontaneous cough or other less invasive procedures. NTS has been used to maintain a patent airway thus ensuring adequate oxygenation and ventilation and avoiding intubation that was solely intended for the removal of secretions.

NTS refers to the insertion of a suction catheter through the nasal passage and pharynx into the trachea without a tracheal tube or tracheostomy (although a nasopharyngeal airway may be used) in order to aspirate accumulated secretions or foreign material.

The clearance of secretions is accomplished by application of subatmospheric pressure applied to a sterile, flexible, multi-eyed catheter on withdrawal only. Appropriate subatmospheric pressures are

  • Neonates: 60-80 mm Hg
  • Infants: 80-100 mm Hg
  • Children: 100-120 mm Hg
  • Adults: 100-150 mm Hg

Negative pressures should not exceed 150 mm Hg as higher pressures have been shown to cause trauma, hypoxemia, and atelectasis.

Settings

NTS is performed in a wide variety of settings, and this guideline applies to patients of all ages.

  • Critical care
  • Emergency room or department
  • Inpatient acute care
  • Extended care and skilled nursing facility care
  • Home care
  • Outpatient or ambulatory care

Indications

The need to maintain a patent airway and remove saliva, pulmonary secretions, blood, vomitus, or foreign material from the trachea in the presence of:

  • Inability to clear secretions when audible or visible evidence of secretions in the large/central airways that persist in spite of patient's best cough effort. This is evidenced by one or more of the following
    • Visible secretions in the airway
    • Chest auscultation of coarse, gurgling breath sounds, rhonchi, or diminished breath sounds
    • Feeling of secretions in the chest (increased tactile fremitus)
    • Suspected aspiration of gastric or upper airway secretions
    • Clinically apparent increased work of breathing
    • Deterioration of arterial blood gas values suggesting hypoxemia or hypercarbia
    • Chest radiographic evidence of retained secretions resulting in atelectasis or consolidation
    • Restlessness
  • To stimulate cough or for unrelieved coughing
  • To obtain a sputum sample for microbiological or cytological analysis

Contraindications

Refer to the "Contraindications" field or see the original guideline document.

Hazards/Complications

Refer to the "Potential Harms" field or see the original guideline document for information.

Limitations of Method

  • NTS is a blind procedure with inherent risks (refer to complications).
  • Risks are increased in a combative or uncooperative patient.
  • Duration of application of subatmospheric pressure, or suction, should be limited to no greater than 15 seconds.
  • Controversy exists concerning possible overuse of this procedure.

Assessment of Need

  • Personnel should perform a baseline assessment for indications of respiratory distress and the need for NTS as recognized by presenting indications listed above. This should include but not be limited to:
    • Auscultation of chest
    • Monitor patient's heart rate
    • Respiratory rate
    • Cardiac rhythm
    • Oxygen saturation
    • Skin color and perfusion
    • Personnel should assess effectiveness of cough.
  • Prepare the patient for the procedure by providing an appropriate explanation along with adequate sedation and pain relief as needed.

Assessment of Outcome

Effectiveness of NTS should be reflected by assessing patient post suction for:

  • Improved breath sounds
  • Removal of secretions
  • Improved blood gas data or pulse oximetry
  • Decreased work of breathing (decreased respiratory rate or dyspnea)

Resources

  • Equipment:
    • Vacuum source
    • Calibrated, adjustable regulator
    • Collection vessel and connecting tubing
    • Sterile, flexible, multiple-eyed suction catheter of appropriate caliber
    • Sterile disposable gloves
    • Sterile water and cup
    • Water-based lubricant and/or normal saline
    • Local anesthetic is sometimes used to reduce discomfort.
    • Nasopharyngeal airway when frequent NTS is required
    • Resuscitation bag with mask

    In the acute care setting, with initiation of NTS, or when working with the unstable patient, the following are recommended:

    • Electrocardiogram (EKG) monitor
    • Oxygen (hyperoxygenation with appropriate delivery device as indicated)
    • Personnel protective equipment for Standard Precautions
    • Stethoscope
  • Personnel:
    • Level I caregiver may be the provider of service after Level II personnel have established need by patient assessment and the first NTS episode has been completed. Level I personnel must demonstrate:
      • Knowledge of proper assembly and use of equipment
      • Knowledge of upper airway anatomy and physiology
      • Ability to recognize secretion retention on auscultation
      • Ability to monitor vital signs and assess patient's condition and response to procedure
      • Ability to recognize and respond to adverse reactions and complications of procedures
      • Ability to employ technique of cardiopulmonary resuscitation when indicated
      • Ability to evaluate and document procedure effectiveness and patient response
    • Level II provider initially assesses the patient, determines the need for NTS, and evaluates response to and effectiveness of first episode. Level II personnel have all the skills of Level I providers plus:
      • Knowledge and understanding of patient's disease, goals, and limitation of NTS
      • Recognition and understanding of basis of pathophysiology
      • Ability to perform initial treatment and be available to troubleshoot the procedure
      • Ability to modify techniques and equipment and take definitive action in response to adverse reaction
      • Ability to detect adverse reactions and avoid patient harm by employing techniques of cardiopulmonary resuscitation with mechanical airway adjuncts and bag-mask devices
      • Knowledge of basic electrocardiogram (EKG) and dysrhythmia recognition
      • Knowledge of signs and symptoms of decreased cardiac output, oxygenation, and perfusion
      • Ability to teach Level I and lay personnel providing home care
    • Home care should be provided by lay personnel trained and knowledgeable in
      • Proper assembly and use of equipment
      • Correct positioning of patient
      • Proper suctioning technique
      • Signs and symptoms of respiratory distress
      • Assessment of patient response to procedure
      • Response to adverse reaction
      • Care and cleaning of equipment

Monitoring

The following should be monitored before, during and following the procedure.

  • Breath sounds
  • Skin color
  • Breathing pattern and rate
  • Pulse rate, dysrhythmia, electrocardiogram (EKG) if available
  • Color, consistency, and volume of secretions
  • Presence of bleeding or evidence of physical trauma
  • Subjective response including pain
  • Cough
  • Oxygenation (pulse oximeter)
  • Intracranial pressure (ICP), if equipment is available
  • Laryngospasm

Frequency

Nasotracheal suctioning should be performed by a skilled caregiver when indicated and when other methods to remove secretions from airway have failed.

Infection Control

  • The Centers for Disease Control and Prevention (CDC) Guidelines for Standard Precautions should be adhered to.
  • All equipment and supplies should be appropriately disposed of or disinfected.

CLINICAL ALGORITHM(S)

None provided

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The type of supporting evidence is not specifically stated for each recommendation.

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

  • American Association for Respiratory Care. Nasotracheal suctioning--2004 revision & update. Respir Care 2004 Sep;49(9):1080-4. [62 references]

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

1992 Aug (revised 2004 Sep)

GUIDELINE DEVELOPER(S)

American Association for Respiratory Care - Professional Association

SOURCE(S) OF FUNDING

American Association for Respiratory Care (AARC)

GUIDELINE COMMITTEE

Not stated

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Primary Author: Kim Bennion, RRT, Primary Children's Medical Center, Salt Lake City, Utah

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Not stated

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: American Association for Respiratory Care (AARC). AARC clinical practice guideline. Nasotracheal suctioning. Respir Care 1992 Aug;37(8):898-901.

GUIDELINE AVAILABILITY

Electronic copies: Available in Portable Document Format (PDF) from the American Association for Respiratory Care (AARC) Web site.

Print copies: Available from the American Association for Respiratory Care (AARC), CPG Desk, 11030 Ables Ln, Dallas, TX 75229-4593; Web site: www.aarc.org.

AVAILABILITY OF COMPANION DOCUMENTS

None available

PATIENT RESOURCES

None available

NGC STATUS

This summary was completed by ECRI on November 30, 1998. The information was verified by the guideline developer on December 15, 1998. This NGC summary was updated by ECRI on March 21, 2005.

COPYRIGHT STATEMENT

This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions.

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo